Pacira Pharmaceuticals Stock Performance
as on September 30, 2026 at 1:15 am IST
Day's Low
Day's High
$25.22$25.59
0.36%
Downside
1.11%
Upside
52 Week's Low
52 Week's High
$18.80$27.6625.72%
Downside
9.28%
Upside
Pacira Pharmaceuticals share price movements today
- Previous Close
- $25.39
- Open
- $25.42
- Volume
- 20.5K
- Market Cap
- $988.4M
- Day's Low - High
- $25.22 - $25.59
- 52 Week Low - High
- $18.80 - $27.66
Pacira Pharmaceuticals Historical Returns
- 1 Month Return
- -1.44 %
- 3 Month Return
- + 1.2 %
- 1 Year Return
- + 0.2 %
- 3 Year Return
- -17.24 %
- 5 Year Return
- -55.24 %
Pacira Pharmaceuticals Stock Fundamentals & Key Indicators
Check Pacira Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$988.4M
EPS (TTM)
0.3521
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.30%
PE Ratio (TTM)
71.34
Industry PE ratio
3.21
PEG Ratio
1.1008200528689618
EBITDA
114.8M
Revenue (TTM)
746.2M
Profit Margin
79.21%
Return On Equity TTM
2.13%
Pacira Pharmaceuticals Stock Valuation
Track how Pacira Pharmaceuticals P/E has moved over time to understand its valuation trends.
Pacira Pharmaceuticals in the last 5 years
Lowest (-8.76x)
December 31, 2024
Industry (3.21x)
December 31, 2025
Today (161.75x)
December 31, 2025
Highest (161.75x)
December 31, 2025
Today’s Price to Earnings Ratio: 161.75x
Pacira Pharmaceuticals vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Pacira Pharmaceuticals with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $988.4M | -55.24% | 71.34 | 79.21% | 0.00% | |
| Buy | $20.4B | 153.36% | 15.73 | 86.14% | 0.00% | |
| Buy | $20.5B | 31.82% | -49.53 | 34.83% | 2.69% | |
| Buy | $39.9B | NA | 18.89 | 65.57% | 1.34% | |
| Buy | $29.4B | -63.37% | 11.69 | 70.87% | 2.94% |
Stock Returns calculator for Pacira Pharmaceuticals Stock including INR - Dollar returns
The Pacira Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Pacira Pharmaceuticals investment value today
Current value as on today
₹1,08,074
Returns
₹8,074
(+8.07%)
Returns from Pacira Pharmaceuticals Stock
Dollar Impact
₹8,193 (+8.19%)
Analyst Recommendation on Pacira Pharmaceuticals Stock
Based on 3 analysts
66.67%
Buy
33.33%
Hold
0.00%
Sell
Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Pacira Pharmaceuticals. Average target price of $30
Pacira Pharmaceuticals Share Price Target
Get share price movements and forecasts by analysts on Pacira Pharmaceuticals.
What analysts predicted
15.63%UPSIDE
Target Price
$30
Current Price
$25.31
Analyzed by
3 Analysts
High
$38
Target
$30.00
Low
$25
Pacira Pharmaceuticals target price $30, a slight upside of 15.63% compared to current price of $25.31. According to 3 analysts rating.
Indian Investors' Interest in Pacira Pharmaceuticals Stock
Search interest for Pacira Pharmaceuticals Stock has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Pacira Pharmaceuticals Quarterly Profit & Loss
All numbers in Millions USD
Pacira Pharmaceuticals Annual Profit & Loss
All numbers in Millions USD
Pacira Pharmaceuticals Quarterly Cash Flow
All numbers in Millions USD
Pacira Pharmaceuticals Annual Cash Flow
All numbers in Millions USD
Pacira Pharmaceuticals News & Key Events
Today's Timeline - 30 June
Tue, 05:00 PM
-Pacira announces divestiture of iovera° to Zimmer Biomet for up to $140 million, enhancing its biopharmaceutical focus.
Insights on Pacira Pharmaceuticals
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, PCRX stock has moved up by 2.8%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 177.37M → 192.39M (in $), with an average increase of 7.8% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 1.63M → 4.65M (in $), with an average increase of 40.6% per quarter
NO EFFECTAgainst Peers
In the last 3 years, United Therapeutics Corporation Common Stock has given 85.3% return, outperforming this stock by 102.5%
- NO EFFECT
Against Peers
In the last 1 year, Viatris Inc. Common Stock has given 89.9% return, outperforming this stock by 89.7%
About Pacira Pharmaceuticals
| Organisation | Pacira Pharmaceuticals |
| Headquarters | 2000 Sierra Point Parkway, Brisbane, CA, 94005, US |
| Industry | Drug Manufacturers - Specialty & Generic |
| CEO | Frank D. Lee |
| E-voting on shares | Click here to vote |
Key Management of Pacira Pharmaceuticals
Name | Title |
|---|---|
Mr. Christopher C. Young | Chief Manufacturing Officer |
Ms. Krys Corbett Esq. | Chief Business Officer |
Mr. Frank D. Lee | CEO & Director |
Ms. Kristen Williams Esq., J.D. | Chief Administrative Officer & Secretary |
Mr. Brendan P. Teehan | Chief Commercial Officer |
Ms. Lauren Bullaro Riker | Principal Accounting Officer & Senior VP of Finance |
Ms. Susan Mesco | Head of Investor Relations |
Mr. Anthony Molloy III, Esq. | Chief Legal & Compliance Officer |
Mr. Shawn M. Cross | Chief Financial Officer |
Dr. Jonathan Slonin M.D. | Chief Medical Officer |
FAQs
What is Pacira Pharmaceuticals share price today?
Pacira Pharmaceuticals share price today is $25.31 as on . Pacira Pharmaceuticals share today touched a day high of $25.59 and a low of $25.22.
What is the 52 week high and 52 week low for Pacira Pharmaceuticals share?
Pacira Pharmaceuticals share touched a 52 week high of $27.66 on and a 52 week low of $18.80 on . Pacira Pharmaceuticals stock price today i.e. is trending at $25.31,which is 8.50% down from its 52 week high and 34.63% up from its 52 week low.
What is Pacira Pharmaceuticals's market capitalisation today?
Pacira Pharmaceuticals market capitalisation is $0.00T as on .
How to invest in Pacira Pharmaceuticals Stock (PCRX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Pacira Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pacira Pharmaceuticals Shares that will get you 0.0593 shares as per Pacira Pharmaceuticals share price of $25.31 per share as on September 29, 2026 at 7:45 pm IST.
What is the minimum amount required to buy Pacira Pharmaceuticals Stock (PCRX) from India?
Indian investors can start investing in Pacira Pharmaceuticals (PCRX) shares with as little as ₹95.980003356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.80 in Pacira Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ).
Based on Pacira Pharmaceuticals share’s latest price of $25.31 as on September 29, 2026 at 7:45 pm IST, you will get 0.3951 shares of Pacira Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Pacira Pharmaceuticals has given to Indian investors in the last 5 years?
Pacira Pharmaceuticals stock has given -55.24% share price returns and 29.19% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?